publication date: Aug. 3, 2010
In this issue: NCI Advisors Approve Recompetition Of $132 Million Proteomic Technologies Network. NCI Places Hold On Genentech Drug Trials, Citing Disagreement Over Intellectual Property Provisions. St. Martin’s Press Buys Rights To Book By Brawley, Goldberg. Collins, Lander, Botstein Win Albany Prize. Download PDF
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.